William Blair Comments on DENTSPLY SIRONA Inc.’s Q2 2024 Earnings (NASDAQ:XRAY)

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – William Blair lowered their Q2 2024 EPS estimates for DENTSPLY SIRONA in a research note issued on Tuesday, June 25th. William Blair analyst B. Vazquez now forecasts that the medical instruments supplier will post earnings per share of $0.51 for the quarter, down from their previous estimate of $0.52. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $2.03 per share. William Blair also issued estimates for DENTSPLY SIRONA’s Q3 2024 earnings at $0.51 EPS, Q4 2024 earnings at $0.55 EPS, FY2024 earnings at $1.99 EPS and FY2025 earnings at $2.32 EPS.

A number of other research analysts have also recently issued reports on the stock. Robert W. Baird cut their target price on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating for the company in a research note on Friday, May 3rd. The Goldman Sachs Group cut their target price on shares of DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating for the company in a research note on Monday, May 6th. StockNews.com cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, May 3rd. Piper Sandler reiterated a “neutral” rating and issued a $32.00 target price (down previously from $35.00) on shares of DENTSPLY SIRONA in a research note on Friday, May 3rd. Finally, Barrington Research cut their target price on shares of DENTSPLY SIRONA from $41.00 to $38.00 and set an “outperform” rating for the company in a research note on Friday, May 3rd. Five analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $34.44.

DENTSPLY SIRONA Stock Down 2.2 %

Shares of XRAY opened at $25.01 on Wednesday. The stock has a market cap of $5.19 billion, a price-to-earnings ratio of -56.84, a P/E/G ratio of 1.14 and a beta of 1.04. The company has a quick ratio of 0.97, a current ratio of 1.43 and a debt-to-equity ratio of 0.54. DENTSPLY SIRONA has a 12 month low of $24.98 and a 12 month high of $41.65. The company has a 50-day moving average price of $28.04 and a two-hundred day moving average price of $31.86.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, hitting analysts’ consensus estimates of $0.42. The firm had revenue of $953.00 million during the quarter, compared to analysts’ expectations of $969.45 million. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The company’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same quarter last year, the company earned $0.39 earnings per share.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several institutional investors and hedge funds have recently made changes to their positions in XRAY. Parkside Financial Bank & Trust lifted its position in DENTSPLY SIRONA by 33.3% during the 4th quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock worth $42,000 after buying an additional 292 shares in the last quarter. Beach Investment Counsel Inc. PA lifted its position in DENTSPLY SIRONA by 1.4% during the 4th quarter. Beach Investment Counsel Inc. PA now owns 22,125 shares of the medical instruments supplier’s stock worth $787,000 after buying an additional 306 shares in the last quarter. Wahed Invest LLC lifted its position in DENTSPLY SIRONA by 9.3% during the 4th quarter. Wahed Invest LLC now owns 3,603 shares of the medical instruments supplier’s stock worth $128,000 after buying an additional 306 shares in the last quarter. VisionPoint Advisory Group LLC lifted its position in DENTSPLY SIRONA by 104.2% during the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after buying an additional 395 shares in the last quarter. Finally, Treasurer of the State of North Carolina lifted its position in DENTSPLY SIRONA by 0.5% during the 3rd quarter. Treasurer of the State of North Carolina now owns 92,842 shares of the medical instruments supplier’s stock worth $3,171,000 after buying an additional 470 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

Insiders Place Their Bets

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 3,577 shares of the stock in a transaction on Friday, May 31st. The stock was purchased at an average price of $27.95 per share, with a total value of $99,977.15. Following the acquisition, the director now owns 58,374 shares of the company’s stock, valued at $1,631,553.30. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 0.52% of the company’s stock.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 12th. Shareholders of record on Friday, June 28th will be issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 2.56%. The ex-dividend date is Friday, June 28th. DENTSPLY SIRONA’s dividend payout ratio is presently -145.45%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.